Nutrigenomics Market Growth Trends, Key Players, and Industry Developments 2024-2028

The Global nutrigenomics market is projected to expand by USD 997.73 million between 2024 and 2028, growing at a CAGR of 13.87%. This growth is driven by increasing investments in nutrigenomics research, the rising prevalence of obesity and chronic diseases, and the demand for personalized nutrition solutions. The market is also supported by initiatives like the NIH Common Fund Metabolomics Program, which promotes nutrigenomics tools, data repositories, and experimental protocols. However, challenges such as low awareness in emerging economies and the complexity of genetic data interpretation pose hurdles to market expansion

For more details about the industry, get the PDF sample report for free

Market Segmentation

By Application

• Obesity

  • The obesity segment is anticipated to witness significant growth during the forecast period.
  • Increasing global obesity rates have led to higher demand for personalized nutrition plans based on nutrigenomic testing.
  • Obesity is linked to several diseases, including osteoporosis, gout, high blood pressure, diabetes, kidney disease, fatty liver disease, and gallbladder disease.
  • Nutrigenomics plays a key role in tailoring dietary interventions to help manage and prevent these conditions.

• Cardiovascular Diseases

  • Nutrigenomics enables precision nutrition strategies to reduce the risk of cardiovascular diseases.
  • Personalized diets can optimize nutrient intake to manage cholesterol levels, blood pressure, and heart health.

• Cancer Research

  • Genomic insights aid in understanding cancer progression and how dietary factors influence gene expression.
  • Nutrigenomics helps in identifying genetic variants associated with cancer risk and response to dietary interventions.

By Product

• Reagents and Kits

  • Reagent kits play a crucial role in DNA extraction, genotyping, and genetic analysis for personalized nutrition interventions.
  • These kits ensure sample integrity and accuracy in nutrigenomics testing.

• Services

  • Genetic testing services enable the identification of nutrient metabolism patterns and dietary needs.
  • These services involve sample collection (saliva, blood), DNA analysis, and tailored nutrition recommendations.

Market Dynamics

Key Market Drivers

• Rising Medical Treatment Costs
  • The increasing prevalence of chronic diseases has led to higher healthcare expenses.
  • According to the Centers for Disease Control and Prevention (CDC), 610,000 people in the U.S. die from heart disease annually.
  • The high cost of branded drugs is prompting individuals to opt for nutrigenomics-based dietary interventions for disease prevention.

Significant Market Trends

• Growing Demand for Personalized Nutrition
  • Consumers are increasingly seeking tailored dietary plans based on their genetic profiles.
  • Genetic testing, biomarker analysis, and AI-driven nutritional insights are transforming the personalized nutrition landscape.
  • This trend is driven by a shift toward preventative healthcare and optimized wellness solutions.

Major Market Challenges

• Low Awareness in Emerging Markets
  • Many developing regions lack awareness and educational resources on nutrigenomics.
  • Limited healthcare infrastructure and public health education hinder adoption.
  • The absence of standardized regulations for nutrigenomics-based interventions further restricts market growth.

Get more details by ordering the complete report

Key Players

• BASF SE
• Cell Logic Pty Ltd
• Cura Integrative Medicine
• DNA Life
• DNANUTRICOACH
• geneOmbio Technologies Pvt. Ltd.
• Genetic Healing
• Genova Diagnostics Inc.
• Greenarray Genomic Research and Solutions Private Limited
• GX Sciences LLC
• Holistic Health International LLC
• Koninklijke DSM NV
• Mapmygenome India
• Metagenics LLC
• My DNA Health Ltd.
• NutriFit Canada
• Nutrigenomix Inc.
• Seaport Diagnostics Inc.
• Vieroots Wellness Solutions Pvt Ltd
• Xcode Life Sciences Pvt. Ltd.

Future Market Insights

The nutrigenomics industry is expected to grow with advancements in genetic sequencing, AI-driven dietary analysis, and increased investments in research and development. The rising focus on personalized nutrition, preventative healthcare, and functional genomics will continue to shape the market. The expansion of nutrigenomics-based diagnostics and interventions will drive further adoption, particularly in North America.